Pharming Group has transitioned from a speculative play to a fundamentally attractive, cash-generating rare disease company.

Thank you to everyone who attended our webinar ‘Antibodies to watch in 2026‘ in association with the journal, mAbs. Below are ...

Pharming Group (NASDAQ:PHAR) outlined its 2026 financial guidance and provided updates on its commercial portfolio and late-stage pipeline during its 2026 Investor Day, emphasizing continued revenue ...

SAN FRANCISCO, Feb 4 (Reuters) - Two U.S. senators this week introduced a bill that would create new rules around the sale of synthetic gene sequences that could be used to create bioweapons.

Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...

The company that brought back the dire wolf is launching a new biovault to store the genomes of the most at-risk species.

DNA's iconic double helix does more than "just" store genetic information. Under certain conditions it can temporarily fold into unusual shapes. Researchers at Umeå University, Sweden, have now shown ...

Colossal Biosciences aims to freeze millions of animal samples in the hope of saving endangered species, or one day resurrecting them.

Novel Quality Controls to Enable QC & Inter-Laboratory Standardization MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix), a life sciences ...